Table 4.
Baseline | 1 M | 3 M | 6 M | 24 M | P value | |
---|---|---|---|---|---|---|
FMFS | 24.00 ± 15.85 | 28.42 ± 16.57 | 29.33 ± 15.68 | 31.54 ± 17.93 | 36.56 ± 17.86* | .010* |
SS | 26.68 ± 18.65 | 30.58 ± 18.54 | 34.17 ± 17.40 | 32.82 ± 17.82* | 39.00 ± 16.73** | .000** |
LAS | 29.36 ± 21.00 | 32.12 ± 20.65 | 33.46 ± 18.63 | 33.32 ± 19.87 | 39.23 ± 19.27 | .205 |
EAS | 29.29 ± 21.41 | 33.31 ± 21.21 | 36.92 ± 19.86* | 33.86 ± 20.08* | 39.14 ± 19.36* | .003* |
GMFM-88-A (Lying and Rolling) | 45.36 ± 11.53 | 47.77 ± 9.98 | 47.33 ± 10.33 | 48.29 ± 8.82 | 47.82 ± 9.91 | .084 |
GMFM-88-B (Sitting) | 39.29 ± 20.57 | 49.85 ± 19.27 | 52.58 ± 16.05 | 50.29 ± 19.08 | 53.36 ± 16.82 | .040* |
GMFM-88-C (Crawling and Kneeling) | 19.79 ± 14.29 | 28.46 ± 14.56 | 31.33 ± 12.15 | 27.29 ± 13.76 | 35.18 ± 12.17 | .014* |
GMFM-88-D (Standing) | 15.86 ± 10.33 | 22.85 ± 11.51* | 25.92 ± 9.42* | 23.14 ± 11.79 | 25.36 ± 10.39** | .001** |
GMFM-88-E (Walking, Running and Jumping) | 14.29 ± 13.60 | 21.77 ± 15.24** | 25.75 ± 17.13** | 26.07 ± 19.21** | 31.18 ± 18.79** | .000** |
GMFM-88-TOTAL | 52.41 ± 24.44 | 66.66 ± 25.02 | 71.45 ± 22.29* | 67.95 ± 24.72* | 74.95 ± 23.84* | .001** |
ADL | 34.54 ± 20.90 | 45.85 ± 24.34** | 52.08 ± 24.38** | 50.82 ± 27.00** | 61.68 ± 26.16** | .000** |
Data are summarized as the mean ± SD (standard deviation). 1 M: 1 month after treatment; 3 M: 3 months after treatment; 6 M: 6 months after treatment; 24 M: 24 months after treatment; GMFM: Gross Motor Function Measure; ADL: Activity of Daily Living; FMFS: Fine Motor Function Scale; SS: Sociability Scale; LAS: Life Adaptability Scale; EAS: Expressive Ability Scale
*P < 0.05; **P < 0.01